Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Inform. 2011 Feb 17;10:13-29. doi: 10.4137/CIN.S6631.

In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis.

Author information

1
Division of Clinical Pharmacology and Toxicology, Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI, USA. email:domski@wayne.edu

Abstract

Aberrant microRNA activity has been reported in many diseases, and studies often find numerous microRNAs concurrently dysregulated. Most target genes have binding sites for multiple microRNAs, and mounting evidence indicates that it is important to consider their combinatorial effect on target gene repression. A recent study associated the coincident loss of expression of six microRNAs with metastatic potential in breast cancer. Here, we used a new computational method, miR-AT!, to investigate combinatorial activity among this group of microRNAs. We found that the set of transcripts having multiple target sites for these microRNAs was significantly enriched with genes involved in cellular processes commonly perturbed in metastatic tumors: cell cycle regulation, cytoskeleton organization, and cell adhesion. Network analysis revealed numerous target genes upstream of cyclin D1 and c-Myc, indicating that the collective loss of the six microRNAs may have a focal effect on these two key regulatory nodes. A number of genes previously implicated in cancer metastasis are among the predicted combinatorial targets, including TGFB1, ARPC3, and RANKL. In summary, our analysis reveals extensive combinatorial interactions that have notable implications for their potential role in breast cancer metastasis and in therapeutic development.

KEYWORDS:

bioinformatics; cancer; computational; metastasis; microRNA

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Libertas Academica Icon for PubMed Central
    Loading ...
    Support Center